Qatari investments in Germany entered the vaccine arena against the Corona pandemic. After the Qatar Investment Authority acquired a stake in the company, CureVac, which manufactured the expected vaccine, about two hundred million dollars, with the beginning of the pandemic, the company’s president, Franz Werner Haas, announced their intention to produce 600 million A dose by the end of this year, and about a billion more in 2022.
On the other hand, Qatari investment in the German market was appreciated by the political leadership in Berlin and economic decision-makers, after it moved towards the small companies sector that represents the lever of the German economy.